Prof. Pei-Wen Cheng is a distinguished academic and researcher specializing in nanomedicine, pharmacology, and metabolic syndrome. She has built a strong career through dedicated research and teaching, advancing innovative approaches in medical sciences. Her academic journey spans several prestigious institutions in Taiwan and abroad, reflecting her global perspective and commitment to scientific excellence. With expertise rooted in natural product research, pharmacological studies, and biomedical applications, she has made significant contributions to the field. Prof. Cheng continues to drive impactful research while mentoring students and collaborating with colleagues, establishing herself as a respected figure in medical education and biomedical research.
Kaohsiung Veterans General Hospital | Taiwan
Author Profile
Google Scholar
Academic Journey
Prof. Pei-Wen Cheng earned her Ph.D. degree from Kaohsiung Medical University’s Graduate Institute of Natural Products. She further advanced her career through postdoctoral research at the Faculty of Medicine, Dalhousie University and later at the Department of Medical Education and Research, Kaohsiung Veterans General Hospital (Taiwan), where she deepened her expertise in medical sciences.
Professional Career
Prof. Cheng began her academic role as an Assistant Professor at National Sun Yat-sen University while also serving as an Assistant Researcher at Kaohsiung Veterans General Hospital. She then advanced to the position of Associate Professor at National Sun Yat-sen University and Associate Researcher at the hospital, where she contributed significantly to both teaching and research. She is currently a Professor at National Sun Yat-sen University, recognized for her impactful contributions to science and education.
Research Interests
Her primary research focuses on nanomedicine, pharmacology, and metabolic syndrome. Prof. Cheng’s innovative work bridges the gap between nanotechnology and biomedical applications, aiming to develop novel therapeutic strategies that improve human health and address critical challenges in modern medicine.
Notable Publications
Current mechanistic concepts in ischemia and reperfusion injury
Authors: Meng-Yu Wu, Giou-Teng Yiang, Wan-Ting Liao, Andy Po-Yi Tsai, Yeung-Leung Cheng, Pei-Wen Cheng, Chia-Ying Li, Chia-Jung Li
Journal: Cellular Physiology and Biochemistry
Year: 2018
Application of time series analysis in modelling and forecasting emergency department visits in a medical centre in Southern Taiwan
Authors: Wang-Chuan Juang, Sin-Jhih Huang, Fong-Dee Huang, Pei-Wen Cheng, Shue-Ren Wann
Journal: BMJ Open
Year: 2017
Resveratrol decreases fructose‐induced oxidative stress, mediated by NADPH oxidase via an AMPK‐dependent mechanism
Authors: Pei‐Wen Cheng, Wen‐Yu Ho, Yu‐Ting Su, Pei‐Jung Lu, Bo‐Zone Chen, Wen‐Han Cheng, Wen‐Hsien Lu, Gwo‐Ching Sun, Tung‐Chen Yeh, Michael Hsiao, Ching‐Jiunn Tseng
Journal: British Journal of Pharmacology
Year: 2014
Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling pathway to modulate central control of blood pressure
Authors: Wen-Han Cheng, Pei-Jung Lu, Wen-Yu Ho, Che-Se Tung, Pei-Wen Cheng, Michael Hsiao, Ching-Jiunn Tseng
Journal: Circulation Research
Year: 2010
Effect of resveratrol on reactive oxygen species-induced cognitive impairment in rats with angiotensin II-induced early Alzheimer’s disease
Authors: Yu-Te Lin, Yi-Chung Wu, Gwo-Ching Sun, Chiu-Yi Ho, Tzyy-Yue Wong, Ching-Huang Lin, Hsin-Hung Chen, Tung-Chen Yeh, Chia-Jung Li, Ching-Jiunn Tseng, Pei-Wen Cheng
Journal: Journal of Clinical Medicine
Year: 2018
Caffeine intake improves fructose-induced hypertension and insulin resistance by enhancing central insulin signaling
Authors: Tung-Chen Yeh, Chun-Peng Liu, Wen-Han Cheng, Bo-Rong Chen, Pei-Jung Lu, Pei-Wen Cheng, Wen-Yu Ho, Gwo-Ching Sun, Jau-Cheng Liou, Ching-Jiunn Tseng
Journal: Hypertension
Year: 2014
Conclusion
Prof. Pei-Wen Cheng exemplifies dedication to advancing scientific knowledge and fostering innovation in medical research. Her career journey from doctoral studies to professorship reflects her commitment to academic excellence and impactful research. With a focus on nanomedicine, pharmacology, and metabolic syndrome, she continues to push the boundaries of biomedical science. Her contributions extend beyond research, encompassing teaching, mentorship, and international collaborations that strengthen academic networks. As a professor, she remains committed to inspiring future scientists while pursuing groundbreaking discoveries. Prof. Cheng’s work demonstrates how multidisciplinary approaches can contribute to improved healthcare outcomes and scientific advancement on a global scale.